141 related articles for article (PubMed ID: 1919005)
1. Characterization of the autoantigen calreticulin.
Rokeach LA; Haselby JA; Meilof JF; Smeenk RJ; Unnasch TR; Greene BM; Hoch SO
J Immunol; 1991 Nov; 147(9):3031-9. PubMed ID: 1919005
[TBL] [Abstract][Full Text] [Related]
2. Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the lambda Ral-1 antigen of Onchocerca volvulus.
Lux FA; McCauliffe DP; Büttner DW; Lucius R; Capra JD; Sontheimer RD; Lieu TS
J Clin Invest; 1992 Jun; 89(6):1945-51. PubMed ID: 1602002
[TBL] [Abstract][Full Text] [Related]
3. A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule".
McCauliffe DP; Zappi E; Lieu TS; Michalak M; Sontheimer RD; Capra JD
J Clin Invest; 1990 Jul; 86(1):332-5. PubMed ID: 2365822
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
Zappi E; Sontheimer R
Immunol Invest; 1993 Apr; 22(3):189-203. PubMed ID: 8509157
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the mouse autoantigen La (SS-B). Identification of conserved RNA-binding motifs, a putative ATP binding site and reactivity of recombinant protein with poly(U) and human autoantibodies.
Topfer F; Gordon T; McCluskey J
J Immunol; 1993 Apr; 150(7):3091-100. PubMed ID: 8454877
[TBL] [Abstract][Full Text] [Related]
6. Major retinal cell components recognized by onchocerciasis sera are associated with the cell surface and nucleoli.
Zhou Y; Dziak E; Unnasch TR; Opas M
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1089-99. PubMed ID: 7510272
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and epitope mapping of a cloned human autoantigen La.
Sturgess AD; Peterson MG; McNeilage LJ; Whittingham S; Coppel RL
J Immunol; 1988 May; 140(9):3212-8. PubMed ID: 2452201
[TBL] [Abstract][Full Text] [Related]
8. Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization.
Eggleton P; Ward FJ; Johnson S; Khamashta MA; Hughes GR; Hajela VA; Michalak M; Corbett EF; Staines NA; Reid KB
Clin Exp Immunol; 2000 May; 120(2):384-91. PubMed ID: 10792392
[TBL] [Abstract][Full Text] [Related]
9. Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognized by sera from patients with onchocerciasis.
Rokeach LA; Zimmerman PA; Unnasch TR
Infect Immun; 1994 Sep; 62(9):3696-704. PubMed ID: 7520419
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of calreticulin in systemic lupus erythematosus.
Eggleton P; Reid KB; Kishore U; Sontheimer RD
Lupus; 1997; 6(7):564-71. PubMed ID: 9302659
[TBL] [Abstract][Full Text] [Related]
11. Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus: anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-ribonucleoprotein.
Scofield RH; Racila DM; Gordon TP; Kurien BT; Sontheimer RD
J Rheumatol; 2000 Jan; 27(1):128-34. PubMed ID: 10648028
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity and filariasis. Autoantibodies against cytoplasmic cellular proteins in sera of patients with onchocerciasis.
Meilof JF; Van der Lelij A; Rokeach LA; Hoch SO; Smeenk RJ
J Immunol; 1993 Nov; 151(10):5800-9. PubMed ID: 7901281
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen.
Ben-Chetrit E; Gandy BJ; Tan EM; Sullivan KF
J Clin Invest; 1989 Apr; 83(4):1284-92. PubMed ID: 2649513
[TBL] [Abstract][Full Text] [Related]
14. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen.
McCauliffe DP; Lux FA; Lieu TS; Sanz I; Hanke J; Newkirk MM; Bachinski LL; Itoh Y; Siciliano MJ; Reichlin M
J Clin Invest; 1990 May; 85(5):1379-91. PubMed ID: 2332496
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a calreticulin-binding nuclear protein as histone (H1), an autoantigen in systemic lupus erythematosus.
Treves S; Bajocchi G; Zorzato F; Govoni M; Trotta F
Lupus; 1998; 7(7):479-87. PubMed ID: 9796851
[TBL] [Abstract][Full Text] [Related]
17. A calreticulin-like protein co-purifies with a '60 kD' component of Ro/SSA, but is not recognized by antibodies in Sjögren's syndrome sera.
Lu J; Willis AC; Sim RB
Clin Exp Immunol; 1993 Dec; 94(3):429-34. PubMed ID: 8252803
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SS-A antigen.
Boehm J; Orth T; Van Nguyen P; Söling HD
Eur J Clin Invest; 1994 Apr; 24(4):248-57. PubMed ID: 8050453
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin synthetic peptide analogues: anti-peptide antibodies in autoimmune rheumatic diseases.
Routsias JG; Tzioufas AG; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
Clin Exp Immunol; 1993 Mar; 91(3):437-41. PubMed ID: 7680295
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen.
Cheng ST; Nguyen TQ; Yang YS; Capra JD; Sontheimer RD
J Immunol; 1996 Jun; 156(11):4484-91. PubMed ID: 8666824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
